Tag: Farxiga

AstraZeneca wraps up $1.8bn acquisition of CinCor Pharma

Raghuram Kadari- February 28, 2023

AstraZeneca has closed the previously announced $1.8 billion acquisition of US biopharmaceutical company CinCor Pharma. Under the terms of the agreement, AstraZeneca acquired all outstanding ... Read More

AstraZeneca to acquire US biopharma company CinCor Pharma for $1.8bn

Raghuram Kadari- January 10, 2023

AstraZeneca has agreed to acquire CinCor Pharma for a transaction value of around $1.8 billion, which includes an upfront cash payment of about $1.3 billion, ... Read More

AstraZeneca scores Chinese approval for heart failure therapy Forxiga

pharmanewsdaily- February 7, 2021

AstraZeneca said that Forxiga (dapagliflozin) has secured approval in China for its use in the reduction of the risk of cardiovascular (CV) death and hospitalization ... Read More

AstraZeneca gets FDA breakthrough status for Farxiga in CKD

pharmanewsdaily- October 4, 2020

AstraZeneca has been granted breakthrough therapy designation (BTD) for Farxiga (dapagliflozin) from the US Food and Drug Administration (FDA) for the treatment of patients with ... Read More

Farxiga : AstraZeneca gets FDA fast track status for heart failure after MI

pharmanewsdaily- July 20, 2020

AstraZeneca has secured fast track designation for Farxiga (dapagliflozin) in the US for its use in reducing the risk of hospitalization for heart failure (hHF) ... Read More